Boston Scientific announces 4-year data for Rezūm BPH treatment

Posted in Medical Device

January 28, 2019 • 2 min read

Boston Scientific (NYSE: BSX) recently announced that data from a randomized clinical trial demonstrate that Rezūm Water Vapor Therapy, a minimally invasive treatment for benign prostatic hyperplasia (BPH), provides durable results and preserves sexual function four years after treatment...